OverviewChartNewsTraderScreen

BAVARIAN NORDIC AS/  DK0015998017  /

Vienna Global Market
6/3/2024  5:32:21 PM Chg. +0.13 Volume Bid5:32:21 PM Ask5:32:21 PM High Low
24.69EUR +0.53% 0
Turnover: -		 -Bid Size: - -Ask Size: - 25.01 24.69
GlobeNewswire 5/31 Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Sm...
GlobeNewswire 4/29 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 4/2 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 2/23 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
GlobeNewswire 11/8/2023 Emergent BioSolutions Reports Third Quarter 2023 Financial Results
TeleTrader 8/19/2022 EU makes monkeypox vaccine more available
TeleTrader 8/18/2022 WH announces new strategies against monkeypox
TeleTrader 7/30/2022 Spain confirms second monkeypox death
TeleTrader 7/29/2022 Spain confirms Europe's first monkeypox death
TeleTrader 7/25/2022 Monkeypox vaccine approved by EU
TeleTrader 7/22/2022 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 3/21/2022 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 2/28/2022 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 2/14/2022 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 12/6/2021 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 12/5/2021 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 9/1/2021 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 8/23/2021 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 8/23/2021 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 8/9/2021 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
GlobeNewswire 6/11/2021 Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
GlobeNewswire 3/8/2021 Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-i...
GlobeNewswire 12/16/2020 Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
GlobeNewswire 8/24/2020 Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Small...
GlobeNewswire 7/22/2020 Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine